Walgreens names new financial head
Walgreens Boots Alliance has tapped a pharmaceutical executive as its next CFO.
The company announced the appointment of James Kehoe, recently CFO and board director of Takeda Pharmaceutical Company Limited, as Walgreens’ executive VP and global CFO, effective June 1. He will be based at the company’s headquarters in Deerfield, Ill.
Kehoe will succeed George Fairweather, who has served as Walgreens Boots Alliance global CFO since February 2015. Fairweather will become a senior advisor to CEO Stefano Pessina for business development and finance, also effective June 1.
Fairweather has been instrumental in the formation of Walgreens Boots Alliance, the subsequent integration of the legacy companies, the new enterprise’s major cost-transformation program and the establishment of the combined global financial organization, according to Walgreens.
Kehoe has been CFO of Takeda Pharmaceutical since June 2016 and was based in Tokyo, reporting directly to the company’s president and CEO. He was appointed to the Takeda Pharmaceutical board of directors in June 2017. He joined Takeda Pharmaceutical from Kraft Foods Group in the U.S., where he last held the role of executive VP, CFO.
The company announced the appointment of James Kehoe, recently CFO and board director of Takeda Pharmaceutical Company Limited, as Walgreens’ executive VP and global CFO, effective June 1. He will be based at the company’s headquarters in Deerfield, Ill.
Kehoe will succeed George Fairweather, who has served as Walgreens Boots Alliance global CFO since February 2015. Fairweather will become a senior advisor to CEO Stefano Pessina for business development and finance, also effective June 1.
Fairweather has been instrumental in the formation of Walgreens Boots Alliance, the subsequent integration of the legacy companies, the new enterprise’s major cost-transformation program and the establishment of the combined global financial organization, according to Walgreens.
Kehoe has been CFO of Takeda Pharmaceutical since June 2016 and was based in Tokyo, reporting directly to the company’s president and CEO. He was appointed to the Takeda Pharmaceutical board of directors in June 2017. He joined Takeda Pharmaceutical from Kraft Foods Group in the U.S., where he last held the role of executive VP, CFO.